T1	Drug_or_compound 0 9	Rofecoxib
T2	Multi-tissue_structure 62 67	Joint
T5	Gene_or_gene_product 225 241	Cyclooxygenase-2
T6	Gene_or_gene_product 243 248	COX-2
T9	Cell 387 395	platelet
T10	Drug_or_compound 434 471	non-steroidal anti-inflammatory drugs
T11	Drug_or_compound 606 615	rofecoxib
T12	Drug_or_compound 719 728	rofecoxib
T13	Multi-tissue_structure 788 794	joints
T14	Drug_or_compound 881 890	rofecoxib
T15	Drug_or_compound 984 993	rofecoxib
T16	Drug_or_compound 1209 1218	rofecoxib
T17	Drug_or_compound 1289 1298	Rofecoxib
T18	Multi-tissue_structure 1351 1357	joints
T20	Gene_or_gene_product 1564 1569	COX-2
T1000	Organism 650 657	patient
T1001	Organism 859 867	patients
T1002	Organism 1040 1047	patient
T1003	Organism 1128 1136	patients
T24	Multi-tissue_structure 942 947	joint
T3	Blood_vessel_development 211 223	angiogenesis
T8	Blood_vessel_development 333 343	angiogenic
*	Equiv T6 T5
T7	Regulation 380 386	affect
E1	Regulation:T7 Theme:T9
A1	Negation E1
T21	Planned_process 616 625	treatment
E2	Planned_process:T21 Instrument:T11 Theme:T1000
T22	Planned_process 732 740	treating
E3	Planned_process:T22 Instrument:T12 Theme:T13
T23	Planned_process 868 875	treated
E4	Planned_process:T23 Theme:T1001 Instrument:T14
T25	Planned_process 994 1003	treatment
E5	Planned_process:T25 Instrument:T15 Theme:T1002
T26	Planned_process 1172 1179	treated
E6	Planned_process:T26 Theme:T1003
T27	Planned_process 1219 1228	treatment
E7	Planned_process:T27 Instrument:T16
T28	Planned_process 1303 1307	used
E8	Planned_process:T28 Instrument:T17 Theme:T18
E9	Blood_vessel_development:T3 
E10	Blood_vessel_development:T8 
T29	Negative_regulation 358 368	properties
E11	Negative_regulation:T29 Theme:E10
